Sensitive, rapid, and simple spectrophotometric methods were developed for determination of the anticancer drugs vinblastine sulfate (VBS) and vincristine sulfate (VCS), which belong to the class of vinca alkaloids. The first method is based on the reaction of VBS and VCS with diazotized dapsone, forming yellow azo products with absorption maxima at 430 nm. The colored species obey Beer's law in the concentration range of 0.5-24 mg/mL for VBS and 0.5-12 mg/mL for VCS. The second method describes the reaction of VBS and VCS with iron(III) and subsequent reaction with ferricyanide in hydrochloric acid medium to yield blue products with absorption maxima at 750 nm. The Beer's law range for this method is 0.1-4 mg/mL for VBS and 0.5-10 mg/mL for VCS. With both methods, colored species were stable for 1 h. The methods are simple and reproducible and are applied for determination of VBS and VCS in pharmaceutical formulations. Commonly encountered pharmaceuticals added as excipients do not interfere in the analysis and the results obtained in the analysis of dosage forms agree well with the labeled contents. V inblastine sulfate (VBS) and vincristine sulfate (VCS) are representatives of a class of dimeric alkaloids containing both the indole and dihydro indole nucleus (1). These are mainly antineoplastic drugs widely used in the treatment of Hodgkin's disease, lymphocytic lymphoma, advanced breast cancer, advanced testicular cancer, acute leukemia, and Kaposi's sarcoma (2-4). Owing to an ever-increasing demand for these anticancer compounds in pharmaceutical preparations, and the challenge to the researchers posed by neoplastic disorders, the present work attempts to meet the demand for their determination. A variety of methods proposed for their determination includes radioimmunoassay (5-7), liquid chromatographic methods (8-13), thin-layer chromatography (14-15), voltammetric methods (16-19), polarography (20), and UV spectrophotometry (21). VBS and VCS are official in the British, Indian, and U.S. Pharmacopeias (22-24). To date, no spectrophotometric method has been developed for the assay of these drugs.
V inblastine sulfate (VBS) and vincristine sulfate (VCS) are representatives of a class of dimeric alkaloids containing both the indole and dihydro indole nucleus (1) . These are mainly antineoplastic drugs widely used in the treatment of Hodgkin's disease, lymphocytic lymphoma, advanced breast cancer, advanced testicular cancer, acute leukemia, and Kaposi's sarcoma (2) (3) (4) . Owing to an ever-increasing demand for these anticancer compounds in pharmaceutical preparations, and the challenge to the researchers posed by neoplastic disorders, the present work attempts to meet the demand for their determination. A variety of methods proposed for their determination includes radioimmunoassay (5-7), liquid chromatographic methods (8) (9) (10) (11) (12) (13) , thin-layer chromatography (14) (15) , voltammetric methods (16) (17) (18) (19) , polarography (20) , and UV spectrophotometry (21) . VBS and VCS are official in the British, Indian, and U.S. Pharmacopeias (22) (23) (24) . To date, no spectrophotometric method has been developed for the assay of these drugs.
We have successfully developed 2 chromogenic reagents for these compounds, and 2 methods that are simple, sensitive, and cost-effective compared with other instrumental techniques which many ordinary laboratories cannot afford. The advantages of the proposed methods are simplicity with respect to reagents, reliability and reproducibility, good sensitivity and stability without the need for extraction. In continuation of our work on spectrophotometric determination of organic compounds of biological activity and pharmaceutical importance (25) (26) (27) (28) (29) (30) , the 2 newly proposed methods provide rapid quantitation of these compounds in pharmaceutical samples. Further, dried plant material of vinca rosea containing these drugs gave positive color reactions for both methods (9) .
Experimental

Instrumentation
Spectrophotometer.-Jasco (Tokyo, Japan) Model UVIDEC-610 UV-Vis with 1.0 cm matched cells was used for all spectral measurements.
Reagents
The following chemicals were used as received in the analysis. 
Procedures
Method A.-A 3.0 mL volume of 0.2% dapsone solution was transferred into each of a series of 25 mL calibrated flasks. The flasks were cooled in an ice bath and 1.0 mL 0.5% aqueous sodium nitrite was added. After cooling for 5 min, 3.0 mL 2% aqueous sulfamic acid was added, and the reaction mixture was cooled for 5 more min with occasional shaking. Aliquots of standard solutions of VBS (12.5-600 µg) and VCS (12.5-300 µg) were added to each flask and heated in a boiling water bath for 5 min. The reaction mixtures in each of the flasks were cooled, water was added, and the flasks were shaken well. The absorbance values for both VBS and VCS were measured at 430 nm against colorless reagent blanks. Calibration graphs were constructed for VBS and VCS.
Method B.-Aliquots of standard solutions of VBS (2.5-100 µg) and VCS (12.5-250 µg) were transferred into a series of 25 mL calibrated flasks, and 1.5 mL 0.01M potassium ferricyanide and 1.5 mL 0.05M Fe(III) were added. A 1.0 mL volume of 1M HCl was added and the flasks were heated in a boiling water bath for 5 min. The flasks were cooled, water was added to each flask, and the solutions were mixed thoroughly. The absorbance values were measured at 750 nm for both VBS and VCS against colorless reagent blanks. Calibration graphs were constructed. 
Procedure for Assay of Injectable Pharmaceutical Preparations
VBS and VCS injections were appropriately diluted with water to obtain the required concentration, and the general procedure for methods A and B were followed. The amounts of VBS and VCS were calculated from calibration graphs.
Results and Discussion
Method A involves the reaction of VBS and VCS with diazotized dapsone to produce yellow azo products with absorption maxima at 430 nm. Method B is based on the reaction of these anticancer drugs with ferric salts in the presence of potassium ferricyanide under mild acidic conditions (1M HCl) to produce blue color with maximum absorption at 750 nm. The latter reaction involves reduction of Fe(III) by VBS and VCS, which subsequently reacts with ferricyanide to form a Prussian blue product in mild acidic medium.
The factors affecting the color development, i.e., reproducibility, sensitivity, and adherence to Beer's law were investigated with VBS as the model compound; VCS behaved similarly.
Absorption Spectra
A yellow azo coupled product was formed when VBS was allowed to react with diazotized dapsone, with absorption maximum at 430 nm for method A. In method B, a blue product with maximum absorption at 750 nm was formed when VBS was allowed to reduce Fe(III) in the presence of ferricyanide under mild acidic conditions. The absorption spectra of both yellow and blue products are shown in Figure 1 . The colorless reagent blanks for both these methods have negligible absorptions at these wavelengths.
Optimization of Analytical Variables
For method A, 0.2% dapsone (1.0-4.0 mL), 0.5% aqueous sodium nitrite (0.5-3.0 mL), and 2% sulfamic acid solution (0.5-3.0 mL) were necessary for maximum color intensity and stability of the yellow products of both VBS and VCS. For method B, 0.01M potassium ferricyanide (0.5-4.0 mL) and 0.05M Fe(III) solution (1.0-4.0 mL) were necessary for maximum color intensity and stability of the blue product. A 1M HCl (0.5-3.0 mL) was used to provide the mild acidic medium for formation of a stable blue product. Although the blue color was formed in the presence of acetic acid, sulfuric acid, or phosphoric acid media, the absorbance readings did not remain constant for more than 10 min. Hence, HCl was chosen as the reaction medium to provide stability of the color and less interference from other excipients present in the drug so- lutions. The required volumes of all reagents were used as mentioned in the recommended procedure. Table 1 shows the details of various optical parameters and precision data for both methods.
Stability
Resultant products of both methods were stable for 1 h. Heating the reaction mixtures for 5 min in a boiling water bath was sufficient to produce stable colored products with maximum color intensity for both methods. However, heating for >5 min produced turbid solutions in both cases.
Interference
The effects of various substances that often accompany these drugs in pharmaceutical formulations were studied. Commonly present pharmaceutical additives such as lactose, glucose, starch, and sucrose do not interfere in the analysis. However, vitamin C interfered seriously in both methods. Table 2 shows the effect of various concomitant substances and their tolerance limits on the determination of these drugs.
Application
The applicability of the methods to the assay of pharmaceutical formulations was examined. The results were cross-checked by official method (22) and found to agree favorably with each other (Table 3 ). The reproducibility of the methods was checked by 5 replicate determinations using 12 µg/mL VBS for method A and 2 µg/mL VBS for method B. Relative standard deviation values were between 0.22 and 0.23%.
Conclusions
The 2 proposed methods are the first of their kind in the literature for spectrophotometric determination of these anticancer drugs. The 2 methods are simple, rapid, highly sensitive, and economical compared to already reported instrumental methods. Hence, these methods are best suited for the assay of these drugs to ensure a high standard of quality control.
